Valence8 US LP 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Valence8 US LP disclosed 40 US equity positions worth $229.4m in its Q3 2024 13F filing. The largest position was QUAL at 26.4% of the reported book, followed by QQQ and IQLT.
What did Valence8 US LP own in Q3 2024? Top 40 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | QUAL ISHARES TR | 26.4% | $60.5m | 337,472 | – | ||
| 2 | QQQ INVESCO QQQ TR | 18.8% | $43.0m | 88,149 | – | ||
| 3 | IQLT ISHARES TR | 18.6% | $42.6m | 1,026,290 | – | ||
| 4 | EFV ISHARES TR | 10.0% | $23.0m | 399,186 | – | ||
| 5 | VTV VANGUARD INDEX FDS | 7.4% | $16.9m | 96,630 | – | ||
| 6 | XLP SELECT SECTOR SPDR TR | 6.0% | $13.7m | 165,267 | – | ||
| 7 | EWU ISHARES TR | 3.4% | $7.8m | 209,344 | – | ||
| 8 | EWJ ISHARES INC | 3.4% | $7.8m | 108,634 | – | ||
| 9 | XLU SELECT SECTOR SPDR TR | 1.8% | $4.2m | 51,940 | – | ||
| 10 | JAZZ JAZZ PHARMACEUTICALS PLC | Healthcare | 0.4% | $999.2k | 8,969 | – | |
| 11 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 0.4% | $920.2k | 17,785 | – | |
| 12 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.3% | $684.6k | 4,585 | – | |
| 13 | INSM INSMED INC | Healthcare | 0.3% | $574.1k | 7,865 | – | |
| 14 | INDIVIOR PLC | 0.2% | $564.2k | 57,293 | – | ||
| 15 | LLY ELI LILLY & CO | Healthcare | 0.2% | $560.8k | 633 | – | |
| 16 | ARGX ARGENX SE | Healthcare | 0.2% | $516.6k | 953 | – | |
| 17 | SLNOEUR SOLENO THERAPEUTICS INC | 0.2% | $490.1k | 9,706 | – | ||
| 18 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.2% | $466.0k | 8,025 | – | |
| 19 | NUVALENT INC | 0.2% | $421.0k | 4,115 | – | ||
| 20 | JANX JANUX THERAPEUTICS INC | Healthcare | 0.2% | $356.9k | 7,857 | – | |
| 21 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 0.1% | $341.6k | 6,684 | – | ||
| 22 | TYRA TYRA BIOSCIENCES INC | Healthcare | 0.1% | $310.1k | 13,188 | – | |
| 23 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.1% | $307.8k | 5,240 | – | |
| 24 | PCVX VAXCYTE INC | Healthcare | 0.1% | $282.0k | 2,468 | – | |
| 25 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 0.1% | $267.6k | 13,020 | – | |
| 26 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 0.1% | $252.0k | 33,650 | – | |
| 27 | 2655787D BLUEPRINT MEDICINES CORP | 0.1% | $242.2k | 2,618 | – | ||
| 28 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 0.1% | $235.6k | 4,241 | – | |
| 29 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.1% | $206.6k | 19,939 | – | |
| 30 | RLAY RELAY THERAPEUTICS INC | Healthcare | 0.1% | $185.5k | 26,200 | – | |
| 31 | ZVRA ZEVRA THERAPEUTICS INC | 0.1% | $149.9k | 21,596 | – | ||
| 32 | ERAS ERASCA INC | Healthcare | 0.1% | $128.1k | 46,923 | – | |
| 33 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.0% | $109.6k | 15,728 | – | |
| 34 | VTGN VISTAGEN THERAPEUTICS INC | 0.0% | $103.5k | 34,376 | – | ||
| 35 | ZURA ZURA BIO LTD | Healthcare | 0.0% | $71.0k | 17,495 | – | |
| 36 | ALEC ALECTOR INC | Healthcare | 0.0% | $68.5k | 14,708 | – | |
| 37 | CLYM ELIEM THERAPEUTICS INC | 0.0% | $61.3k | 12,045 | – | ||
| 38 | CYPH LEAP THERAPEUTICS INC | 0.0% | $47.6k | 18,511 | – | ||
| 39 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.0% | $33.9k | 26,107 | – | |
| 40 | KEZAR LIFE SCIENCES INC | 0.0% | $16.3k | 21,136 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.